New treatments

Good news for Switzerland: US is fast-tracking psychedelics for mental health

Trump holds up executive order in favour of research and access to psychedelic treatments for mental health in the White House's Oval office.

This content was published on May 11, 2026 Switzerland is the only country in Europe offering psychedelic treatments, but access remains extremely limited for patients. US support means things could change. An analysis by Swissinfo.

Novartis opens seventh plant in the United States

New treatments

Swiss pharma firm Novartis plans seventh US plant

This content was published on Apr 30, 2026 Novartis is expanding its production capacity in the United States, with the announcement of a new site in Morrisville, North Carolina. This plant will bring to seven the number of new sites planned as part of its $23 billion investment plan.

Artificial placenta clarifies risks of medication for pregnant women

New treatments

Bern researchers develop artificial placenta to test medicine

This content was published on Apr 30, 2026 Bern scientists create an artificial placenta to safely test drugs for pregnant women.

New treatments

What will be the next obesity blockbuster?

This content was published on Apr 22, 2026 What will the next generation of obesity drugs look like?

Health systems

How Switzerland bought rapid access to Covid vaccines

This content was published on Apr 21, 2026 Switzerland released full Covid vaccine contracts, revealing the prices and terms it took for rapid access to vaccines during the pandemic.

Novartis CEO joins Anthropic's supervisory board

AI and medicine

Novartis CEO joins Anthropic’s board of directors

This content was published on Apr 15, 2026 Novartis CEO Narasimhan joins Anthropic's board, as the AI firm eyes an IPO and healthcare expansion.

Best of SRG content

Therapy app for depression to be available in Switzerland

This content was published on Apr 15, 2026 Doctors in Switzerland will be able to prescribe the Deprexis app for depression starting in July.

New treatments

Can Swiss pharma giant Roche reshape the obesity market?

This content was published on Apr 2, 2026 Swiss pharmaceutical firm Roche is investing billions in new obesity treatments in hopes of breaking into a highly competitive market.

New treatments

Switzerland’s bitter-sweet news for Alzheimer’s patients

This content was published on Feb 27, 2026 Swissmedic was expected to approve two drugs for Alzheimer‘s disease. But it only approved one. What happened?

Roche obtains FDA approval to treat a form of leukaemia

New treatments

FDA approves Roche leukaemia treatment

This content was published on Feb 20, 2026 Genentech obtains FDA approval for treatment for chronic lymphocytic leukaemia (CLL).

New treatments

Popular Stories

Most Discussed

New treatments

More

Good news for Switzerland: US is fast-tracking psychedelics for mental health

More

Swiss pharma firm Novartis plans seventh US plant

More

Bern researchers develop artificial placenta to test medicine

More

What will be the next obesity blockbuster?

More

How Switzerland bought rapid access to Covid vaccines

More

Novartis CEO joins Anthropic’s board of directors

More

Therapy app for depression to be available in Switzerland

More

Can Swiss pharma giant Roche reshape the obesity market?

More

Switzerland’s bitter-sweet news for Alzheimer’s patients

More

FDA approves Roche leukaemia treatment

Popular Stories

Most Discussed